Results 181 to 190 of about 11,970 (271)

Chronic Lymphocytic Leukemia Young Patient in steady state on Zanubrutinib Diagnosed with Cat Scratch Disease via Next-Generation Sequencing. [PDF]

Mediterr J Hematol Infect Dis
Luan C, Yang X, Dong L, Zhu Y, Zhao H.
europepmc   +1 more source

Pyrexia in juvenile dogs: a retrospective analysis of diagnosis and clinical features of 115 Australian cases

Australian Veterinary Journal, Volume 104, Issue 6, Page 356-364, June 2026.
Pyrexia is a non‐specific clinical sign associated with many diseases in dogs. This case series examines the final diagnoses, breed distribution and outcomes in dogs aged 18 months or under with pyrexia >24 h duration. Medical record databases of 11 Australian emergency and referral hospitals between 1st January 2020 and 31st January 2025 were searched
H Lobegeier, J Campo, C Cannon, P Bennett   +3 more
wiley   +1 more source

From Genetic Engineering to Preclinical Safety: A Study on Recombinant Human Interferons. [PDF]

Int J Mol Sci
Ramos TI, Villacis-Aguirre CA, Lamazares E, Manrique-Suárez V, Sandoval F, Culqui-Tapia CN, Martin-Solano S, Mansilla R, Cabezas I, Sánchez O, Donoso-Erch S, Parra NC, Contreras MA, Santiago-Vispo N.   +13 more
europepmc   +1 more source

MRD‐negative conversion with daratumumab monotherapy in newly diagnosed multiple myeloma patients in ≥VGPR/MRD‐positive after first‐line therapy: Final analysis of the open‐label, single‐arm multicentric phase 2 trial DART4MM

British Journal of Haematology, Volume 208, Issue 6, Page 2069-2078, June 2026.
In newly diagnosed multiple myeloma patients in ≥Very Good Partial Remission (VGPR) after a first‐line therapy daratumumab as consolidation/maintenance improved long‐term minimal residual disease negativity. Summary Daratumumab is approved for front‐line and relapsed myeloma therapy.
Alessandro Gozzetti, Paola Pacelli, Federico Caroni, Donatella Raspadori, Elena Bestoso, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Adele Santoni, Luca Puccetti, Francesca Bacchiarri, Ludovica Pengue, Dania Tocci, Irene Attucci, Maria Livia del Giudice, Miriana Ruggieri, Alessandra Lombardo, Anna Marina Liberati, Veronica Candi, Vincenzo Sammartano, Alessandra Cartocci, Anna Sicuranza, Sara Galimberti, Alessandro Maria Vannucchi, Monica Bocchia   +24 more
wiley   +1 more source

tVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
Experimental design and key findings. Four groups (Control+Sham, Control+tVNS, LPS+Sham, LPS+tVNS; n = 7 each) underwent serum ELISA, brain Western blot, and behavioral testing. tVNS altered serum Haptoglobin, IL‐6, CGRP1, and VE‐Cadherin levels, reversed LPS‐induced increases in brain IL‐1β, HMGB1, Haptoglobin, PAR‐2, and CGRP, and alleviated LPS ...
Kerem Atalar, Ece Alim, Aysen Calikusu, Elif Gulcicek Abbasoglu Topa, Hale Gok Dagidir, Meltem Bahcelioglu, Neslihan Bukan, Fusun Erten, Kazım Sahin, Saadet Özen Akarca Dizakar, Hayrunnisa Bolay   +10 more
wiley   +1 more source

Assessment of Pyrogenic Response of Medical Devices and Biomaterials by the Monocyte Activation Test (MAT): A Systematic Review. [PDF]

Int J Mol Sci
Gimenes I, Spoladore J, Paranhos BA, Romasco T, Di Pietro N, Piattelli A, Mourão CF, Gomes Alves G.   +7 more
europepmc   +1 more source

Successful use of haemoperfusion therapy in an adult horse with hepatic encephalopathy and cholangiohepatitis

Equine Veterinary Education, Volume 38, Issue 6, Page e307-e314, June 2026.
Summary A 4‐year‐old, 520 kg, American Quarter Horse broodmare, approximately 90 days in foal, was presented to Texas A&M University Teaching Hospital for suspected liver disease. Based on clinicopathological values and hepatic abnormalities noted ultrasonographically, the mare was presumptively diagnosed with cholangiohepatitis.
A. C. Trimble, S. H. White‐Springer, S. Alpini, E. Rumfola, A. N. DiSilvestro, Y. Ueda, K. Hobbs   +6 more
wiley   +1 more source

Drug‐induced hypersensitivity syndrome followed by exacerbation of Crohn's disease

Pediatric Investigation, Volume 10, Issue 3, Page 288-290, June 2026.
Mei Kamidani, Ryo Tanaka, Hiroshi Oue, Risa Fukuda, Rena Hashimoto, Ichiro Takeuchi, Takako Yoshioka, Naoya Tonegawa, Akira Ishiguro, Katsuhiro Arai, Kazue Yoshida   +10 more
wiley   +1 more source

Effect of Body Mass Index on the Efficacy and Safety of Esaxerenone Versus Trichlormethiazide for the Treatment of Japanese Patients with Uncontrolled Essential Hypertension: A Subanalysis of the Excite‐HT Study

The Journal of Clinical Hypertension, Volume 28, Issue 6, June 2026.
ABSTRACT This prespecified, exploratory, body mass index (BMI)‐stratified analysis of the randomized, open‐label EXCITE‐HT study examined whether esaxerenone elicits a blood pressure (BP)‐lowering effect similar to trichlormethiazide in Japanese patients with uncontrolled essential hypertension.
Tomohiro Katsuya, Kazuomi Kario, Mitsuru Ohishi, Tatsuo Shimosawa, Kazuhito Shiosakai, Taketoshi Furugori, Takashi Taguchi, the EXCITE‐HT investigators   +7 more
wiley   +1 more source

Gossypiboma‐associated sarcomas in five cases

Journal of Small Animal Practice, Volume 67, Issue 6, Page 520-527, June 2026.
Objectives To report clinical presentation, treatment and outcome of dogs and cats diagnosed with gossypiboma‐associated sarcoma. Materials and Methods Referral centres within the United Kingdom, Europe, North America and Australia were contacted to search medical records for dogs and cats with documented gossypiboma‐associated sarcoma and included if ...
G. Thomas, L. Doeven, A. Guillén, D. Brockman, E. Herbert, S. Priestnall, J. Helm, K. Shimura, M. Simpson   +8 more
wiley   +1 more source